CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis Adenosine and adenosine receptor-mediated action in coronary microcirculation Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar MINOCA: a heterogenous group of conditions associated with myocardial damage Initial Invasive or Conservative Strategy for Stable Coronary Disease Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology

Review Article2020 Apr 24;126(9):1107-1111.

JOURNAL:Circ Res. Article Link

How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research

P Libby , KE Bornfeldt. Keywords: allergy and immunology; atherosclerosis; CAD; endothelium; thrombosis.

Full Text PDF